https://www.reuters.com/article/us-health-coronavirus-moderna-vaccine-idUSKBN26L3H8

11 0

FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020. REUTERS/Brian Snyder. (Reuters) - Moderna Inc will not be ready to apply for emergency authorization for its potential COVID-19 vaccine before the U.S. presidential election in November, the Financial Times reported on Wednesday, citing the company’s chief executive officer. Stéphane Bancel told FT that he did not expect to have full approval to distribute the drug to all sections of the U.S. population until next spring. ( on.ft.com/36h2LXD ). Moderna did not immediately respond to Reuters request for comment. Full story

30 September

wait